1Muh. Arfah Syam , 2Margaretha Solang ,3Widy Susanti Abdulkadir
1,2,3Department of Public Health, Postgraduate, Gorontalo State University, Gorontalo City
DOI : https://doi.org/10.47191/ijmra/v7-i06-20Google Scholar Download Pdf
ABSTRACT:
Tuberculosis is a disease caused by the bacteria Mycobacterium tuberculosis. Tuberculosis does not only occur in the lungs, which is called pulmonary tuberculosis but can occur outside the lung organs, which is called extrapulmonary tuberculosis. Reinfection from Pulmonary tuberculosis to Extrapulmonary tuberculosis can occur due to several factors. This study aims to determine the factors that can influence the occurrence of reinfection Extrapulmonary tuberculosis in pulmonary tuberculosis sufferers. Method Analytical research with a cross-sectional approach. The number of samples was 49 samples of Pulmonary tuberculosis sufferers who underwent initial diagnosis at the Anatomical Pathology Laboratory, Prof. Dr. Hi. Aloei Hospital. Saboe Gorontalo City. The results of the study showed that the variables Adherence to treatment (p: 0.047), and BCG Vaccine (p: 0.018) were < α value: 0.05, while the significance value of comorbidity for EPTB Reinfection was (p: 0.991). The conclusion is that adherence to treatment and the BCG vaccine have a significant effect on the incidence of reinfection Extrapulmonary tuberculosis (EPTB) in patients with pulmonary tuberculosis (PTB), while comorbidities do not have a significant effect on the incidence of reinfection Extrapulmonary tuberculosis (EPTB) in patients with pulmonary tuberculosis (PTB).
KEYWORDS:Tuberculosis, Extrapulmonary tuberculosis, Pulmonary tuberculosis.
REFERENCES1) Arikunto, S. (2018). Prosedur Penelitian: Suatu Pendekatan Praktik.
2) Barreto, M. L., Pereira, S. M., Pilger, D., Cruz, A. A., Cunha, S. S., Sant’Anna, C., Ichihara, M. Y., Genser, B., & Rodrigues, L. C. (2011). Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: Second report of the BCG-REVAC cluster-randomised trial. Vaccine, 29(31), 4875–4877. https://doi.org/10.1016/j.vaccine.2011.05.023
3) Bhattacharya, P., Talukdar, K., Barman, B., Jamil, M., Phukan, P., Mobing, H., War, G., Nonglait, P. L., Murti, S., Prithviraj, K., & Sangma, B. (2020). Clinical Spectrum and Medical Comorbidities in Tuberculosis: A Hospital-Based Study in Northeast India. Cureus, 12(9). https://doi.org/10.7759/cureus.10580
4) Central TBC Division. (2023). Training Module On Extrapulmonary Tuberculosis.
5) Helwig, N. E., Hong, S., & Hsiao-wecksler, E. T. (2018). MIKRO AND NANOTECHNOLOGI IN VACCINE DEVELOPMENT.
6) Houda Ben, A., Makram, K., Chakib, M., Khaoula, R., Fatma, H., Fatma, S., Mariem Ben, H., Sourour, Y., Imed, M., Jamel, D., & Mounir Ben, J. (2018). Extrapulmonary Tuberculosis: Update on the Epidemiology, Risk Factors and Prevention Strategies. International Journal of Tropical Diseases, 1(1), 1–6. https://doi.org/10.23937/ijtd-2017/1710006
7) Kemenkes RI. (2020). Strategi Nasional Penanggulangan Tuberkulosis di Indonesia 2020-2024. Pertemuan Konsolidasi Nasional Penyusunan STRANAS TB, 135.
8) Notoatmodjo, S. (2018). METODOLOGI PENELITIAN KESEHATAN.
9) Qian, X., Nguyen, D. T., Lyu, J., Albers, A. E., Bi, X., & Graviss, E. A. (2018). Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis article. Emerging Microbes and Infections, 7(1). https://doi.org/10.1038/s41426-018-0106-1
10) Setiani, L. A., Almasyhuri, & Hidayat, A. A. (2022). Evaluasi Kepatuhan Pasien Pada Penggunaan Obat Antidiabetik Oral Dengan Metode Pill-Count dan MMAS-8 Di Rumah Sakit PMI Kota Bogor. Jurnal Ilmiah Ilmu Terapan Universitas Jambi, 6(1), 32–46.
11) World Health Organization. (2022). Framework for collaborative action on tuberculosis and comorbidities.
12) World Health Organization. (2023). Report 2023. In January: Vol. t/malaria/ (Issue March.)
Volume 07 Issue 06 June 2024
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 07 Issue 07 (July 2024).
PUBLICATION DATES:
1) Last Date of Submission : 26 July 2024 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.